ABSTRACT This study characterizes regulatory elements of collagen 2α1 (col2a1) in Xenopus that enable transgene expression in cartilage-forming chondrocytes. The reporters described in this study drive strong cartilage-specific gene expression, which will be a valuable tool for further investigations of Xenopus skeletal development. While endogenous col2a1 mRNA is expressed in many embryonic tissues, its expression becomes restricted to tadpole and adult chondrocytes. This chondrocyte-specific expression is recapitulated by col2a1 reporter constructs, which were tested through I-SceI meganuclease-mediated transgenesis. These constructs contain a portion of the Xenopus tropicalis col2a1 intron, which aligns to a cartilage-specific intronic enhancer that has been well characterized in mammals. Two overlapping regions of the first intron that are 1.5-Kb and 665-bp long, both of which contain this enhancer sequence, drove EGFP expression in both larval and adult chondrocytes when connected to an upstream promoter. However, neither a truncated 155-bp region that also contains the enhancer, nor a separate 347-bp intronic region that lacks it, was able to drive cartilaginous transgene expression. The two cartilage-specific transgenes are heritable in F1 progeny, which exhibit none of the background expression observed in the injected founders. This study is the first to use the I-SceI technique to characterize an enhancer element in Xenopus, and the first to generate chondrocyte-specific gene expression in a nonmammalian vertebrate. The creation of novel cartilage-specific gene expression provides a new tool for further studies of anuran skeletal development.
hancer sequence from over 3-Kb to 800-bp (Horton et al., 1987 ), 182-bp (Zhou et al., 1995 , 48-bp (Zhou et al., 1998) and 18-bp (Lefebvre et al., 1996) regions, each of which is capable of driving chondrocyte expression when connected to a col2a1 promoter. The mouse minimal enhancer contains the HMG recognition sequence, CATTCAT, which binds to the HMG-box containing transcription factor Sox9 (Lefebvre et al., 1997) . However, multiple copies of the truncated 48 bp and 18 bp enhancer regions are required for detectable expression of reporter genes, indicating the presence of additional regulatory information outside the Sox9-binding region.
The tissue-specificity and high level of expression generated by the col2a1 promoter/enhancer have provided a valuable tool for studies of gene function within the chondrocyte lineages of mice. Variations of this reporter construct have been used for over-expression of dominant-negative and full-length genes within mouse chondrocyte lineages (Nakata et al., 1993; Tsumaki et al., 1999; Takeda et al., 2001; Ueta et al., 2001; Stricker et al., 2002) . The mouse reporter construct also has been fused to both doxycycline and tamoxifen-inducible enhancers, allowing temporal control of chondrocyte-specific gene expression (Grover and Roughley, 2006; Nakamura et al., 2006; Chen et al., 2007) .
To date, the use of a cartilage-specific reporter has been limited to studies in mammals. No other vertebrate taxon has a similar tool for driving transgene expression in chondrocytes. The development of a col2a1 reporter in alternative species (and classes) would allow investigations of both comparative gene Col2a1 is expressed again in the adult cranial cartilages, including the post-metamorphic nasal septum (NS), planum terminale (PT) planum antorbitale (PA), and alary cartilage (AC). (E,F) Midmetamorphic, stage-57 tadpole. Coronal histological sections of the nasal capsule, stained by in situ hybridizations with col2a1 and sox9 probes. (E) Col2a1 expression increases in the alary (AC) and superior prenasal (SPC) cartilages as they form during metamorphosis. (F) Up-regulation of col2a1 corresponds with heightened expression of sox9 in these cartilages during metamorphic chondrogenesis. Additional abbreviations: NC, nasal capsule; EY, eye. Scale bar, 0.5 mm.
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regulation and comparative skeletal development. Metamorphosing anurans are ideal taxa for this type of investigation given their unique skeletal development, which is associated with a biphasic life history. Metamorphic development of the anuran skeleton differs from that of amniotes in having two discrete periods of skeletogenesis. The first, embryonic phase of skeleton formation yields the strictly cartilaginous tadpole skeleton. The second, metamorphic phase of skeleton formation results in both new cartilage and bone formation in the post-metamorphic froglet (reviewed in . Previous investigations have concentrated on the cellular origins of the tadpole skull (Stone, 1929; Sadaghiani and Thièbaud, 1987; Olsson and Hanken, 1996) and the differentiation of tadpole chondrocytes (Spokony et al., 2002; Baltzinger et al., 2005; Kerney et al., 2007) . Few studies, however, have investigated the cellular origins and differentiation of chondrocytes during the second-metamorphic-phase of anuran skull development (e.g., Gross and Hanken, 2008) . This lack of research is largely attributable to the long period required for tadpoles to complete metamorphosis, and a lack of long-term genetic tools needed to manipulate and analyze metamorphic processes.
This study investigates the regulation of col2a1 in Xenopus using I-SceI meganuclease-mediated transgenics and provides a tool for future investigations of anuran skeletal development. This transgenic technique was originally used in a teleost, the Japanese medaka (Oryzias latipes; Thermes et al., 2002) , and later adapted for the creation of transgenic Xenopus (Ogino et al., 2006 a,b; Pan et al., 2006) . The technique allows for the efficient transfection of embryos through simple enzyme digestion and microinjection. This study is the first to employ this transgenic technique for the characterization of an enhancer element in Xenopus. The cartilage-specific reporter construct described in this study will facilitate further investigations into the genetic basis of anuran skeletal development and metamorphosis.
Results

In situ hybridizations
After an initial distribution in several embryonic tissues, expression of col2a1 mRNA becomes restricted to the cartilaginous skeleton of the tadpole and later of the adult frog. In stage 33/34 embryos, col2a1 is expressed in the floor plate of the neural tube, the notochord, branchial arches, somites, and otic vesicles (Fig. tained within the aligned X. tropicalis sequence. The 48-bp mouse enhancer contains two inverted repeats that are conserved with the rat and human Col2a1 intronic sequences (Lefebvre et al., 1996) . Only the outer repeat (TGAAT) is conserved with X. tropicalis (Fig. 2C) . Its inverted repeat (ATTCA) appears 30 base pairs downstream and is within the seven-base Sox9 binding region (CATTCAT; Lefebvre et al., 1997) , which is strictly conserved between mouse and X. tropicalis. Two additional putative with conserved nucleotides shown in red; gaps and substitutions are black. The two yellow boxes correspond to two putative HMG binding sites of weak affinity described from the mouse sequence (Zhou et al., 1998) . The red underline corresponds to the nucleotide region that is essential for binding Sox9 protein to the mouse enhancer (Lefebvre et al., 1997) . The purple boxes correspond to a conserved inverted repeat (Lefebvre et al., 1996) , which is separated by 30 bp and has a downstream portion inside the Sox9 binding region. (D) Schematic depiction of the reporter constructs used in this study. The col2a1 5´ promoter region was connected to the (A, B, C, and D) intronic sequences to drive the expression of EGFP. A separate gamma-crystallin promoter was used to drive lens-specific expression of GFP as a positive control for transfection of injected embryos. Two 18-bp I-SceI recognition sites flank each reporter construct. . By stage 46, col2a1 is strongly and exclusively expressed in larval chondrocytes (e.g., ceratobranchial cartilages; Fig. 1C ). During metamorphosis, new cartilages contribute to the adult nasal capsule and sound-conducting plectral apparatus (Trueb and Hanken, 1992; Gross and Hanken, 2008) . Metamorphic formation of alary and superior prenasal cartilages in the nasal capsule corresponds with heightened col2a1 mRNA expression (Fig. 1E ) along with coexpression of the col2a1 regulator sox9 (Fig. 1F) . By stage 64, col2a1 is strongly expressed in post-metamorphic cartilages of the froglet, including the nasal capsule (Fig. 1D ).
Promoter characterization
Previous research on the chondrocyte-specific expression of Col2a1 in mammals indicated a synergism between the 5´ promoter and intronic enhancer (Savagner et al., 1990; Leung et al., 1998; Seki et al., 2003) . Therefore, 491 bp of upstream sequence from Xenopus tropicalis was used as a promoter in each transgene construct characterized in this study ( Fig. 2A) . This sequence includes 366 bp of regulatory DNA and 125 bp of 5´-untranslated region (UTR). A LAGAN/Vista analysis revealed no significant sequence similarity between the mouse and X. tropicalis promoter regions (data not shown). However, a sequence 13 bp upstream of the transcription start site (TATAACT) in X. tropicalis is identical to the TATAbox sequence of the mouse Col2a1 promoter ( Fig.  2A ), but not the human COL2A1 TATA-box (TATAACGG) (Osaki et al., 2003) . While both the human and mouse Col2a1 promoters share a TFIIB recognition sequence (GGGMGCA) upstream of the TATA-box (Osaki et al., 2003) , this sequence is not found in the X. tropicalis promoter. The X. tropicalis col2a1 promoter region also contains a putative binding site for the delta EF1 transcription factor, based on a TFSearch analysis (95% minimal threshold score with vertebrate matrices; http://www.cbrc.jp/research/ db/ TFSEARCH.html; Heinemeyer et al., 1998) , which is not found in the mouse or human promoter ( Fig. 2A) .
Intron characterization
The LAGAN/Vista alignment of the first col2a1 intron from mouse and Xenopus tropicalis reveals a 144-bp sequence that aligns with 74.3% sequence identity (Fig. 2B, C ). This region overlaps only the first 69 base pairs of the 182-bp mouse enhancer (Zhou et al., 1995) . However, the truncated 48-bp and 18-bp (Lefebvre et al., 1996) enhancer sequences are con-HMG binding sites (Zhou et al., 1998) are not conserved between mouse and X. tropicalis intronic sequences (Fig. 2C ).
I-SceI meganuclease-mediated transgenesis
A region of the col2a1 promoter and 5´ UTR was connected to three separate regions of the first col2a1 intron and linked to egfp. Each construct was injected into zygotes of Xenopus laevis along with I-SceI meganuclease. The resulting embryos were screened for separate lens-specific GFP expression under the control of the gamma-crystallin promoter, which was used as a positive control for transgene uptake (Rankin et al., 2009) . Injection of each construct generates EGFP expression in a subset of epidermal cells early in development in most injected animals (Table 1 ). This shared expression may be due to expression driven by the 5´-promoter region itself, or it may be an artifact of the egfp injection (Pan et al., 2006) . No construct drives detectable EGFP expression similar to the col2a1 mRNA expression in the notochord, otic vesicle, somites, floor plate of the neural tube, or branchial arches during early development (Fig. 1A, B) .
The 347-bp intronic region 'A' does not overlap with the aligned region from our Vista analysis (Fig 2B) . This sequence was used as a negative control and compared to the expression generated by intronic sequences that contain the aligned enhancer. A reporter construct containing intronic sequence A does not drive expression outside the lens and early epidermal cells (Fig. 3B , Table 1 ). Epidermal expression dissipates in later-stage tadpoles. No other pattern of EGFP is found in any additional larval tissue.
The reporter construct that contains the 1,517-bp region 'B' of the first intron (Fig. 2B ) drives EGFP expression in the cartilaginous skeleton (Fig. 3C-D 
EXPRESSION OF EGFP IN TADPOLES INJECTED WITH FOUR REPORTER CONSTRUCTS
"Total transgenic" refers to the number of injected tadpoles with GFP expressed in the lens under the gamma-crystallin promoter (positive control). Chondrocyte expression in transgenic tadpoles (with lens-specific GFP expression) was scored between stages 42 and 47 for each intronic region assayed.
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sion within cartilage (data not shown), while the other twelve show nearly complete expression within cartilage that is distributed on only one side of the tadpole (Fig. 3C, 4B ). The stronger unilateral expression indicates continued integration of the transgene after the first cell division. Cartilaginous EGFP expression co-localizes with collagen-II antibody reactivity in the ceratobranchial cartilages ( Fig. 4A-B) . Expression of EGFP driven by this construct is strong during early cartilage-forming stages (40-42) but decreases later (stage 48-metamorphosis). This may be due to an increase in production of the extracellular matrix and spreading of the chondrocyte lacunae, or to weaker activation of the col2a1 regulatory sequences in later stages. Cartilaginous EGFP expression increases in post-metamorphic cartilages of the nasal capsule (Fig.  4 C-D) , which also express col2a1 mRNA ( Fig. 1D-E) . Proliferative chondrocytes of the radio-ulna and humerus also express EGFP under this reporter (Fig. 4 E-F) . EGFP is not expressed, however, in either articular or hypertrophic chondrocytes of the radio-ulna (Fig. 4F) . Col2a1 mRNA expression diminishes in hypertrophic chondrocytes of mice and chickens, where type II collagen is largely replaced by type X collagen before endochondral ossification (reviewed in Goldring et al., 2006) . Seven tadpoles express EGFP in a small number of axial myocytes; this gradually diminishes in later tadpole stages. A half-transgenic female carrying the B construct was bred to a wild-type male. Bilateral cartilaginous EGFP expression is observed in 24 of 110 progeny. These 24 individuals consistently express EGFP in the cartilaginous skeleton with no variation among individuals, which indicates a single integration of the transgene (Marsh-Armstrong et al., 1999) . Early chondrocyte expression is strong (stages 40-42). Later EGFP expression (stage 48) is reticulate within individual cartilages (Fig. 3D) .
The reporter construct with the 665-bp intronic region 'C' also drives EGFP expression in the cartilaginous skeleton, although its expression is less intense than that generated by intronic region B (Figs. 3E-G, 4G-H) . EGFP-expressing chondrocytes occur in 20 of 78 tadpoles transfected with this reporter (25.6%; Table 1 ). Nine of these have stronger unilateral expression (Fig. 3E) , while eleven exhibit weaker sporadic expression that is distributed bilaterally in the early cartilaginous skeleton. Early cartilaginous expression of EGFP dissipates by stage 48 and is undetectable in later-stage chondrocytes (Fig. 3G) . As with construct B, however, EGFP is strongly expressed in metamorphic cartilages of the nasal capsule in froglets that carry construct C (Fig. 4H) . Myocyte expression also occurs in ten of the injected tadpoles, although it dissipates in later stages.
A half-transgenic female carrying the C construct, again with strong unilateral EGFP expression, was bred to a wild-type male. The resulting progeny have bilateral cartilaginous expression of EGFP by stage 40 (Fig. 3F) , which dissipates entirely by stage 48 (Fig. 3G) . The transgene was inherited in approximately half (18 of 30) of the F1 progeny. The F1 generation of construct C exhibits more variation in the distribution of EGFP and has twice the proportion of transgenic individuals compared to the F1 genera-
tion of construct B, which indicates multiple transgene insertions in the maternal founder. Despite this increased number of insertions, cartilaginous expression of EGFP generated by construct C is weaker than that generated by construct B in stage-matched, F1 progeny (Fig. 3D, G) . The reporter construct that carries the 155-bp intronic region 'D' does not drive expression in any tissue outside the early epidermis (Fig. 3H) . Although this construct contains the entire aligned intronic enhancer region (Fig. 2B) , it fails to drive EGFP expression in myocytes or chondrocytes of 22 transgenic tadpoles, all of which express GFP in the lens under the control of the gamma-crystallin promoter (Table 1) .
Discussion
This study describes the expression of col2a1 mRNA in larval, metamorphic and post-metamorphic Xenopus laevis and characterizes reporter constructs that use a transcriptional enhancer element from X. tropicalis' col2a1 in X. laevis tadpoles and adults. This enhancer element is located in the 3' region of the first intron and aligns closely with a well-characterized chondrocyte-specific mouse enhancer. The Xenopus enhancer, combined with a fragment of the 5´ promoter, drives cartilaginous EGFP expression in I-SceI meganuclease-mediated transgenic tadpoles and adults. These transgenes are heritable through the germ line and are expressed both in larval cartilages that form during embryogenesis and in adult cartilages, which form de novo during metamorphosis and are not present in the larval stage.
Whereas several studies examine the early distribution of col2a1 mRNA in Xenopus laevis (Su et al., 1991; Bieker and Yazdani-Buicky, 1992; Larrain et al., 2000; Kerney et al., 2007) , this study is the first to investigate its expression through metamorphosis (Fig. 1 ). An initially widespread embryonic expression of col2a1 becomes restricted to the cartilaginous skeleton of the larva and continues to be strongly expressed in chondrocytes during subsequent stages. Formation of adult cartilages in the nasal capsule during metamorphosis coincides with an increase in mRNA expression of both col2a1 and the transcription factor sox9. This transcriptional regulator is essential for chondrocyte differentiation (Akiyama et al., 2002) and early col2a1 expression (Lefebvre et al., 1997) in mice. Expression of sox9 during metamorphic chondrogenesis may either coincide with the late differentiation of mesenchymal precursors into functioning chondrocytes or reflect an increase of type II collagen production by existing larval chondrocytes to create new cartilage. Post-metamorphic cartilages of the nasal capsule continue to express col2a1 mRNA after they are fully formed.
Several studies in mammalian cell culture characterize other positive and negative regulatory elements in the Col2a1 promoter region (Savagner et al., 1990 (Savagner et al., , 1995 Seki et al., 2003; Osaki et al., 2003) . An Sp1 binding region (Savagner et al., 1995) and two Ebox silencer regions in the rat promoter (CIIS1 and CIIS2; Savagner et al., 1990) are not found in the 3.6 Kb upstream sequence of the X. tropicalis promoter (data not shown). However, the presence of a putative delta EF1 binding site in the Xenopus tropicalis promoter ( Fig. 2A) indicates a possible site of transcriptional regulation. Delta EF1 is a zinc finger homeobox-1 transcription factor (zfhx1). Null mutant mice that lack functional Delta EF1 have fused limb cartilages and fusions of the carpal and tarsal cartilages in neonates (Takagi et al., 1998) . Delta ef1 mRNA is expressed in paraxial mesoderm, migratory cranial neural crest, retina and neural tube of Xenopus laevis embryos (van Grusven et al., 2006) . Delta EF1 acts as both a repressor of E2-box mediated transcription in mice (Sekido et al., 1994) and Smadmediated BMP signaling in Xenopus (van Grusven et al., 2006) . However, studies of the mouse Col2a1 promoter have not identified Delta EF1 as a potential transcriptional silencer. Further research in the binding of Delta EF1 to the Xenopus promoter is needed to validate its role in col2a1 regulation and anuran skeletogenesis.
Lagan/Vista alignment of the first intron from col2a1 in mouse and Xenopus tropicalis reveals a 144-bp region with 74.3% sequence identity. This sequence contains the seven-base Sox9 binding region from the mouse intron (CATTCAT; Lefebvre et al., 1997) , which is strictly conserved with the X. tropicalis sequence. Part of this recognition sequence exists as an upstream inverted repeat, which also is found in the mouse enhancer (Lefebvre et al., 1996) . Pairs of inverted Sox-binding sites have been characterized in the enhancer of a precursor gene for type XI collagen, col11a2. These are essential for chondrocyte-specific transcriptional activity in col11a2 as well (Bridgewater et al., 2003) . However, additional sequences outside the repeated binding domains are required for the col11a2 enhancer to drive transgene expression in chondrocytes. Other regulatory information may also exist outside the conserved col2a1 enhancer region. Together, Sox6 and L-Sox5 cooperate with Sox9 to activate col2a1 expression in chondrocytes (Bell et al., 1997) . Their binding sites in the col2a1 regulatory regions have not been identified in either mammals (Lefebvre and Smits, 2005) or X. tropicalis.
While the one established Sox9 binding site in the col2a1 enhancer is conserved between mouse and Xenopus, two additional putative HMG binding sites (Zhou et al., 1998) are not (Fig.  2C) . The Sox9 protein does not bind to either of these putative sites in the mouse intron (Lefebvre et al., 1997) . Absence of these sites from the Xenopus sequence further suggests that these sites are not part of the Sox9 regulation of col2a1.
Regulatory ability of the intronic enhancer from Xenopus tropicalis was tested in X. laevis through I-SceI meganucleasemediated transgenesis. A large 1.5-Kb region of the intron drove cartilaginous expression in both tadpole and adult cartilages when connected to an upstream promoter (Fig. 2B, region B) . While a smaller 665-bp region also drove cartilage-specific expression, its expression was weaker than the larger intronic fragment B (Fig. 2B, region C) . A truncated 155-bp region containing the entire aligned sequence from the LAGA/Vista analysis failed to drive any expression (Fig. 2B, region D) . These results are similar to previous studies of the mouse Col2a1 intronic enhancer, in which multiple copies of smaller enhancer regions are required to drive cartilaginous gene expression (Lefebvre et al., 1996; Zhou et al., 1998) . Multiple copies of region D were not tested in this study.
The negative-control construct A, which contains the 5´-promoter (491 bp) but not the conserved intronic enhancer, failed to show any EGFP expression in chondrocytes. Intronic region A (347 bp) is shorter than B (1.5 Kb) and C (665 bp) regions that do drive cartilage-specific expression. The small size of A may account for its inability to drive cartilage-specific expression. The decreasing sizes of regions B, C and D correspond with a decrease in their effectiveness in driving cartilage-specific expression (Table 1) . This trend has been observed in studies of mouse Col2a1 regulation, where smaller enhancer-containing fragments require multiple copies to activate transcription (Zhou et al., 1998; Lefebvre et al., 1996) . However no study of a mammalian col2a1 first intron has revealed regulatory information outside the Sox9-binding enhancer region. The rat col2a1 5´-promoter (310 bp) is capable of driving faint expression in chondrocytes without the intronic enhancer (Horton et al., 1987) . However, neither 6.1 Kb of the human promoter (Leung et al., 1998) nor 309 bp of the mouse promoter (Zhou et al., 1995) drives chondrocyte expression without the intronic enhancer in transgenic mice. Xenopus, like human and mouse, appears to require intronic enhancer sequence for chondrocyte-specific expression.
The mouse enhancer also can drive chondrocyte-specific expression when connected to a minimal human β-globin promoter (Zhou et al., 1995) . Surprisingly, the Col2a1 enhancer (4 copies of 264 bp) from the extinct "marsupial wolf" Thylacinus cynocephalus can drive chondrocyte-specific transgene expression in transgenic mice when connected to the β-globin promoter (Pask et al., 2008) . However, a similar β-globin promoter construct, with 308 bp of the human COL2A1 intronic enhancer, does not drive chondrocyte-specific expression in mice (Leung et al., 1998) .
Expression of EGFP in X. laevis tissues under the control of X. tropicalis regulatory information further supports the previously suggested compatibility of the two species (Khokha et al., 2002) . Zygotes of X. laevis are larger and easier to microinject than those of X. tropicalis. However, the longer generation time in X. laevis makes germ line transmission of transgene constructs difficult to test within a reasonable time frame. Founder frogs bred in this study required 18 months to reach sexual maturity in the laboratory. Compatibility in regulatory sequence function between these species also suggests the possibility that the col2a1 reporters described here will drive transgene expression in cartilages of other amphibians. The I-SceI meganuclease method of transgene integration works in the Mexican axolotl, Ambystoma mexicanum (Sobkow et al., 2006) , and similar microinjection techniques have been developed for the Oriental fire-bellied toad, Bombina orientalis (Olsson and Hanken, 1996; Olsson et al., 2001) , which suggests the feasibility of testing the col2a1 reporter in a wide number of alternative amphibian models.
The meganuclease technique does yield some mosaic expression of EGFP among individual chondrocytes for each reporter tested. This mosaic expression is dramatically reduced in "halftransgenic" tadpoles, which strongly express EGFP unilaterally on either the left or right side. EGFP expression is consistently more intense in the cartilages of half-transgenic tadpoles than in "full-transgenic" individuals, which express cartilaginous EGFP bilaterally (Fig. 3) . Half-transgenic individuals result from incorporation of the transgene after the first cellular division. The transgene is heritable provided the germ line cells carry the inserted construct (Pan et al., 2006) .
Background expression from the reporter construct was observed in epidermal cells and larval myocytes. It is reduced in older tadpoles and post-metamorphic froglets, and absent in F1 progeny. This pattern indicates that the background is a result of injected egfp DNA, and not due to integrated transgene expression.
Conclusions
Cartilage-specific expression generated by these reporter constructs provides a useful tool for future investigations of anuran skeletal development. These constructs can be used to drive dominant-negative protein expression or to over-express various genes in the cartilaginous skeleton. Whereas several studies investigate the skeletal morphology of Xenopus laevis during development (Bernasconi, 1951; Sedra and Michael, 1957; Sokol, 1977; Trueb and Hanken, 1992) , few examine the underlying transcriptional regulators involved in skeletogenesis (Pasqualetti et al., 2000; Spokony et al., 2002; Moriishi et al., 2005; Kerney et al., 2007) . Despite ongoing use of Xenopus as a model system of organogenesis (Thomsen, 2006) and the quickly growing field of skeletal developmental biology (Karsenty, 2003; Zelzer and Olsen, 2003; Hall, 2005; Goldring et al., 2006) few studies research skeletal development in Xenopus. This lack of attention is due largely to the limited array of techniques available for investigations of later development in Xenopus (Blitz et al., 2005) . Functional experiments through the injection of morpholino oligonucleotides, antisense RNA, or RNA interference are limited to early stages (Nutt et al., 2001; Khokha et al., 2002) . Due to these limitations, there are no current investigations into the function of skeletal regulatory genes during anuran metamorphosis. The ability to drive chondrocyte-specific gene expression in Xenopus will provide a valuable tool for future investigations of gene function and cell lineage in anuran skeletal development.
Materials and Methods
All animal protocols were approved by the Harvard University Faculty of Arts and Sciences Standing Committee on the use of Animals in and Dalhousie University's Committee on Laboratory Animals (protocol 07-126).
In situ Hybridizations
Antisense mRNA probes were prepared from pCS2-AS-collagen II (Larrain et al., 2000) and pGEMT:Sox9 (Spokony et al., 2002) . Wholemount in situ hybridizations were performed on albino embryos and hatchlings following the protocol of Sive et al. (2000) . Embryos were fixed in MEMFA and stored in 70% methanol at -20 o C prior to initial use. In situ hybridizations on sectioned tissues followed the protocol of Zelzer et al. (2001) . Sectioned tissues were fixed in 4% paraformaldehyde in phosphate-buffered saline (pH 7.4), dehydrated and embedded in Paraplast X-tra (Sherwood Medical, Deland, FL), and cut to a thickness of 7 μm on a rotary microtome (Leica 1512, Wetzlar, Germany).
Regulatory Region Analysis
The Xenopus tropicalis col2a1 promoter and first intron sequence are from scaffold 161 of the Joint Genome Institute X. tropicalis draft genome assembly version 4.1 (http://genome.jgi-psf.org/cgi-bin/ runAlignment?db=Xentr4). The transcription start site was determined by aligning the complete coding sequence of X. tropicalis col2a1 (Genbank Accession: BC063191) with the genomic sequence. A Lagan/ Vista analysis (Brundo et al., 2003) aligned the enhancer sequence between the first introns of mouse Col2a1 (NCBI accession NW_001030577.1; base pair positions and X. tropicalis col2a1 (JGI scaffold 161; base pair positions 125221-121349). The mouse-specific repeat masker was used for the mouse sequence; the "softmask" option was used for the X. tropicalis se-quence (http://lagan.stanford.edu).
Preparation of Plasmid Constructs
Regulatory sequences and egfp were inserted into the pDHG_I-SceI plasmid (Daniel Buchholz, unpublished) . This plasmid also contains a gamma-crystallin promoter that drives gfp within the I-SceI recognition sites (Fig. 2D-E) . This strong promoter is used to screen injected animals that are successfully transformed with an injected construct (Pan et al., 2006) . Egfp was taken from the pCS2+egfp-Bgl2 plasmid (Turner and Weintraub, 1994) . The 5´-promoter region and first intron of the Xenopus tropicalis col2a1 gene were amplified by PCR. The forward primer 5´-GCA CTG CAC ATG TTC TTG CT-3´ and reverse primer 5´-GCA GAA TCT TTG TGG GGA AA-3´ were used to amplify ~3 Kb of the 5´ promoter region. The forward primer 5´-GTT CGC AGC CAC ACA AGT C-3´ and reverse primer 5´-CCC AGT GTC ACA GAC ACA GAT T-3´ were used to amplify ~3.2 Kb of the first intron. Internal primers were used to amplify 491 bp of the promoter with additional 5´-Hind III and 3´-Sac1 sites. Intronspecific internal primers were used to amplify four regions of the intron with additional 5´-SacI and 3´-HindIII sites. The resulting intronic fragments are 347 bp (A), 1,517 bp (B), 665 bp (C), and 153 bp (D) (Fig. 2B) . Whereas regions B-D each overlapped the sequence aligned by Vista analysis, region A did not; it was used as a negative control for enhancer activity. Orientation of each promoter-intron was determined through PCR and sequencing. The four reporter constructs were used for I-SceI meganuclease-mediated transgenics in Xenopus laevis zygotes.
I-SceI Meganuclease-Mediated Transgenics
The I-SceI transgenic protocol followed those described previously for Xenopus (Ogino et al., 2006 a,b; Pan et al., 2006) . A total of 200 ng plasmid DNA was digested for 40 min at 37 o C in a 23-μL I-SceI meganuclease reaction (New England Biolabs, Ipswich, MA). During this digest fertilized Xenopus laevis eggs were obtained and dejellied using established protocols (Sive et al., 2000) . A total of 4.5 nL of the reaction mix was injected into each single-celled zygote (40 pg DNA/ embryo) using a Femtojet microinjector (Eppendorf, New York). Embryos were raised for 2 hr at room temperature. Individuals that failed to undergo normal cell division were culled. Remaining embryos were raised to embryonic stages 36-40 (Nieuwkoop and Faber, 1994) and screened for GFP expression in the lens under the control of the gamma-crystallin promoter. Incorporation of the transgene after the first cell division yields "half-transgenic" embryos that exhibit unilateral fluorescence on either left or right sides. Incorporation of the transgene before the first cell division yields "full-transgenic" individuals with bilateral transgene expression. Transgenic embryos were raised to early tadpole stages 42-47 and screened for tissue-specific EGFP expression. Tadpoles with intense EGFP expression were raised through metamorphosis to examine reporter expression in adult cartilages.
Antibody Staining and Histology
Antibody staining was carried out on sectioned material following established Xenopus protocols (Gross et al., 2006) . Briefly, tadpoles were fixed overnight in 4% PFA at 4 o C, embedded in OCT media (Sakura, Torrance, CA), frozen, and sectioned at 10 μm on a Leica CM 3050S cryostat. Primary antibodies included a FITC-conjugated goat polyclonal antibody to GFP (1:2000; Abcam, Cambridge, MA) and an anti-collagen II monoclonal antibody (1:100; Linsenmeyer and Hendrix, 1980) . Slides were counterstained with a 2 μg per mL DAPI nuclear stain solution (Invitrogen) before being cover-slipped with Fluoromount-G (Fisher Scientific, Waltham, MA). Serial sections of post-metamorphic tissues were stained with the Hall-Brunt-Quadruple stain, which colors cartilage blue (Hall, 1986) .
